Aquestive Therapeutics Inc (AQST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 77,893 | 89,870 | 95,200 | 23,872 | 24,917 |
| Receivables | 9,684 | 5,998 | 8,324 | 8,471 | 8,550 |
| Inventories | 7,021 | 6,966 | 7,734 | 6,769 | 7,079 |
| TOTAL | $96,570 | $104,011 | $113,379 | $40,966 | $42,457 |
| Non-Current Assets | |||||
| PPE Net | 3,848 | 3,921 | 4,046 | 4,179 | 4,551 |
| Intangibles | 0 | 0 | 1,239 | 1,278 | 1,317 |
| Other Non-Current Assets | 9,540 | 9,673 | 10,859 | 10,995 | 11,123 |
| TOTAL | $13,388 | $13,594 | $16,144 | $16,452 | $16,991 |
| Total Assets | $109,958 | $117,605 | $129,523 | $57,418 | $59,448 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 7,597 | 5,720 | 10,546 | 8,948 | 14,600 |
| Accrued Expenses | 5,025 | 5,674 | 4,637 | 6,497 | 5,468 |
| Other current liabilities | 1,000 | 1,000 | 910 | 922 | 985 |
| TOTAL | $15,152 | $13,895 | $18,058 | $18,308 | $24,057 |
| Non-Current Liabilities | |||||
| Long Term Debt | 31,253 | 30,006 | 28,759 | 27,508 | 34,555 |
| Deferred Revenues | 1,048 | 1,046 | 1,551 | 1,551 | 2,637 |
| Other Non-Current Liabilities | 88,707 | 87,426 | 87,050 | 85,744 | 71,031 |
| TOTAL | $140,226 | $139,189 | $147,766 | $145,597 | $138,318 |
| Total Liabilities | $155,378 | $153,084 | $165,824 | $163,905 | $162,375 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 91,178 | 91,060 | 91,039 | 73,301 | 66,767 |
| Common Shares | 91 | 91 | 90 | 69 | 67 |
| Retained earnings | -346,159 | -334,650 | -331,905 | -319,077 | -310,966 |
| TOTAL | $-45,420 | $-35,479 | $-36,301 | $-106,487 | $-102,927 |
| Total Liabilities And Equity | $109,958 | $117,605 | $129,523 | $57,418 | $59,448 |